News on government policy and legislation impacting life science and diagnostics.
Among the tests that French national health insurance system will reimburse are IGRA tests, including ones from Qiagen and Oxford Immunotec, for screening TB.
GHTC, an advocacy group, said that member nations must contribute needed financial resources so that WHO can implement an effective diagnostics guide.
QuantiFeron-TB Gold Plus is an immunoassay that detects the release of interferon-gamma as a proxy for latent tuberculosis infection.
Entering a new chapter with a new leader, ACLA lends support to a draft bill that would regulate lab tests not as medical devices but as in vitro clinical tests.
The legislation would establish an alternative approach for reviewing a subset of moderate-risk Class II devices.
